Net Income - Kilitch Drugs (India) Ltd (NSE:KILITCH) - Alpha Spread
K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 346.75 INR 3.48%
Market Cap: 5.6B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kilitch Drugs (India) Ltd
Net Income Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Net Income
â‚ą193.5m
CAGR 3-Years
56%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Net Income
â‚ą72B
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Net Income
â‚ą59B
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Net Income
â‚ą110.9B
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Net Income
â‚ą48.1B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Net Income
â‚ą23.5B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Kilitch Drugs (India) Ltd's Net Income?
Net Income
193.5m INR

Based on the financial report for Jun 30, 2024, Kilitch Drugs (India) Ltd's Net Income amounts to 193.5m INR.

What is Kilitch Drugs (India) Ltd's Net Income growth rate?
Net Income CAGR 3Y
56%

Over the last year, the Net Income growth was 61%. The average annual Net Income growth rates for Kilitch Drugs (India) Ltd have been 56% over the past three years .

Back to Top